Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT00006968
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed advanced renal cell cancer
* No bone metastases
* No CNS disease
* Must have an allogeneic donor available
PATIENT CHARACTERISTICS:
Age:
* Over 18
Performance status:
* ECOG 0-1
Life expectancy:
* 3 to 6 months
Hematopoietic:
* Hemoglobin at least 10 g/dL
* Complete blood count normal
Hepatic:
* Bilirubin no greater than 3 times upper limit of normal (ULN)
* Transaminases no greater than 4 times ULN
* No evidence of portal hypertension
Renal:
* Creatinine no greater than 2.0 mg/dL
* No uncontrolled hypercalcemia
Cardiovascular:
* No New York Heart Association class 3 or 4 heart disease
Pulmonary:
* DLCO at least 40% of predicted
Other:
* No severe functional neurological impairment
* HIV negative
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* No more than 1 prior biologic therapy
Chemotherapy:
* No more than 6 months of prior chemotherapy
Endocrine therapy:
* At least 1 year since prior steroids
Radiotherapy:
* Not specified
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00006968
Study Brief:
Protocol Section:
NCT00006968